Go to content Go to the menu Go to the search

PartnersSorbonne University
Quick access, personalized services
Immunological Biotherapies: Concepts and Development


The programme is organized in 4 modules, each module being given in two or three days a week (six to nine hours in a week).

Teaching course will be in English in the form of recorded video conferences. Students and lecturers will have the opportunity to discuss on an open forum.


The courses will shaped as follows:

  • 45 minutes of courses
  • 15 minutes discussion


Module 1 - Mechanisms of action of immunomodulatory agents

Principles and definitions of immunotherapies; antibodies; cytokines and chemokines; cell-based therapy; genetic vaccines; CRISPR-based therapy.

Module 2 - Cancer immunotherapy

Immunotherapies enhancing anti-tumor immunity or targeting T-cell inhibitory molecules; Chimeric Antigen receptors (CARs); Vaccines/cytokines; allogeneic stem cell transplantation for haematological malignancies; Chekpoint inhibitors, NK-based therapy.

Module 3 - Immunotherapy of chronic inflammation

Inflammatory Bowel Disease, Psoriasis, Rheumatoid Arthritis, Diabetes, Atherosclerosis, Allergic diseases and Ashma; Multiple sclerosis.

Module 4 - Vaccine development in infectious diseases

Human Immunodeficiency Virus, Flu viruses, Dengue, Malaria, Tuberculosis, Chagas disease, Ebola, Chikungunya, Shigella, Rheumatic Fever; Zika.


Program IS-IBCD 2018


Traductions :

    Contact us

    Miriam MERAD 
    François LEMOINE
    Roger CHAMMAS
    Rachel Fabre -  Secretary
    Miriam Merad, MD, PhD, is a Professor of Oncological Science and of Medicine (Hem/Onc division) at the Icahn School of Medicine at Mount Sinai in New York.
    Dr. Merad’s laboratory studies the mechanisms that regulate the...

    » Read more